Autologous c-Met/PD-L1-specific CAR T-cells - CISMeF
Autologous c-Met/PD-L1-specific CAR T-cellsNCIt concept
Preferred Label : Autologous c-Met/PD-L1-specific CAR T-cells;
NCIt synonyms : Autologous c-Met/PD-L1-specific CAR T-lymphocytes; Autologous Anti-c-Met/PD-L1 CAR T-cells;
NCIt definition : A preparation of autologous T-lymphocytes that have been transduced with a lentiviral
vector encoding a chimeric antigen receptor (CAR) specific for human hepatocyte growth
factor receptor (HGFR or c-Met) and the immunosuppressive ligand, programmed cell
death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential antineoplastic
activities. Upon infusion, the autologous c-Met/PD-L1-specific CAR T-cells bind to
and induce selective toxicity in c-Met- and PD-L1-expressing tumor cells. cMET, a
receptor tyrosine kinase that is overexpressed or mutated in many tumor cell types,
plays a key role in cancer cell growth, survival, angiogenesis, invasion, and metastasis.
PD-L1 is also overexpressed by many human cancer cell types and plays a key role in
the downregulation of the immune system and tumor evasion from host immunity.;